NSN 6505-01-100-5017 · NIIN 011005017 · FSC 6505
NO DASHES 6505011005017
In Stock
PANCRELIPASE CAPSULES
Drugs and Biologicals
Technical characteristics
5 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CSGS | ADMINISTRATION | ORAL |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| FEAT | SPECIAL FEATURES | ACTIVE MEDICAMENT MEDICINAL STRENGTH:30000.000 MILLIGRAMS OF AMYLASE ACTIVE INGREDIENTS;8000.000 MILLIGRAMS OF LIPASE ACTIVE INGREDIENTS;30000.000 MILLIGRAMS OF PROTEASE ACTIVE INGREDIENTS |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |